Concerto's clinical trial, ENS-002 for Atopic Dermatitis in Adults, is now recruiting.More information
Tap into the microbial world.
We measure, map, and harness the microbial world to create best-in-class products. Welcome to a new generation of efficacy—through ecology.
SolutionsReliable products powered by
Reliable products powered by
microbial ecology.
The biggest challenge in microbe-based products? Making them work outside the lab. Concerto’s deep ecological insights translate to real-world efficacy for skincare issues, chronic disease, nutrition, and more.
TechnologyThe right data
The right data
at AI scale.
Microbial communities are complex. We make them predictable and engineerable. kChip experimentally generates vast ecological datasets, and our kAI model learns from them—mapping interactions, predicting behavior, and enabling the smartest microbial products.
Latest News & Press
From Concerto • 5 21 2025
Concerto Biosciences Maps Skin Microbial Interactions Through Millions of Tested Combinations
From Concerto • 1 29 2025
Concerto Biosciences Announces Appointment of Dr. Stewart Campbell to Board of Directors
Dermatology Times • 11 20 2024
Concerto Biosciences Doses First Participant in Phase 1 Trial of ENS-002, a Microbiome-Based Therapy for Atopic Dermatitis
Harness microbial ecology with Concerto to develop new, transformative products.
Partner With UsMicrobes, like humans, are stronger together than they ever could be alone.
Visit Us
750 Main Street
Cambridge, MA 02139
© 2025 Concerto Biosciences, Inc. All rights reserved.